* Kodiak Sciences Inc KOD.OQ KOD.O is expected to show
no
change in quarterly revenue when it reports results on November
12 (estimated) for the period ending September 30 2024
*
* LSEG's mean analyst estimate for Kodiak Sciences Inc is
for a
loss of 90 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 3 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Kodiak
Sciences
Inc is $3.00, below its last closing price of $4.81.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2024 -0.87 -0.87 -0.86 Beat 1.4
Mar. 31 2024 -1.06 -1.07 -0.82 Beat 23.2
Dec. 31 2023 -0.68 -0.77 -1.13 Missed -46.1
Sep. 30 2023 -1.31 -1.21 -0.95 Beat 21.3
Jan. -1.00 -1.14 -1.53 Missed -34.1
1 0001
Mar. 31 2023 -1.21 -1.33 -1.35 Missed -1.8
Dec. 31 2022 -1.53 -1.35 Beat 11.5
Sep. 30 2022 -1.77 -1.77 -1.47 Beat 16.9
This summary was machine generated November 8 at 15:50 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)